|
|
Centers for Disease Control and Prevention Division of Cancer Prevention and Control 4770 Buford Hwy, NE MS K-64 Atlanta, GA 30341-3717 Call: 1 (800) CDC-INFO TTY: 1 (888) 232-6348 FAX: (770) 488-4760 E-mail: cdcinfo@cdc.gov Submit a Question Online |
United States Food and Drug AdministrationThe United States Food and Drug Administration (FDA) affirmed public health protection role and mission include:
FDA has more than 9,000 employees, located in 167 U.S. cities. Among its staff, FDA has chemists, microbiologists, and other scientists, as well as investigators and inspectors who visit 16,000 facilities a year as part of their oversight of the businesses that FDA regulates. Authorized by Congress to enforce the Federal Food, Drug, and Cosmetic Act and several other public health laws, the agency monitors the manufacture, import, transport, storage, and sale of $1 trillion worth of goods annually. Among its responsibilities is the regulation of medical devices. The FDA's Center for Devices and Radiological Health (CDRH) develops and implements national programs to protect the public health in the fields of medical devices and radiological health. These programs are intended to assure the safety, effectiveness, and proper labeling of medical devices; to promote quality in mammographic services; and to control unnecessary human exposure to potentially hazardous radiation, and to ensure the safe, effictive use of such radiation. Partnership ActivitiesThe Mammography Quality Standards Act (MQSA) was passed in 1992 to ensure all women have access to quality mammography; the National Mammography Quality Assurance Advisory Committee (NMQAAC) was mandated under this act. Since 1993, DCPC has advised the NMQAAC on issues related to MQSA, including CDC-related issues that are relevant to the proceedings of the committee. These subjects have ranged from mammography quality assurance to risks of infectious diseases associated with performing mammography. In addition, since 2001, DCPC has participated in an FDA panel that reviews pre-marketing applications for approval of human papillomavirus (HPV)-related laboratory tests (HPV infection is a risk factor for developing cervical cancer). The FDA is also a part of CDC's National Breast and Cervical Cancer Early Detection Program (NBCCEDP) advisory committee. United States Food and Drug Administration
Page last reviewed: September 26, 2006 Page last updated: September 26, 2006 Content source: Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion |
|
||||||||||||
|